Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS, MRCP (Ireland), MRCP (Glasgow)
Gastroenterologist
MBBS, FCPS (Gastroenterology), SCE Gastroenterology (UK), ESB Gastroenterology (EU)
Gastroenterologist
MBBS, FCPS (Gastroenterology), SCE Gastroenterology (UK), ESB Gastroenterology (EU)
Internal Medicine Specialist
MBBS, MRCP (UK)
Consultant Physician
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Internal Medicine Specialist
MBBS, FCPS (Medicine), MACG (USA), FCPS (Gastroenterology), SCE (U.K)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MACG (USA), FCPS (Gastroenterology), SCE (U.K)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures